Search Result

Results for "

PIK3

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Akt (4) Apoptosis (2) Autophagy (3) Insulin Receptor (1) mTOR (1) Organoid (2) PI3K (5) Ser/Thr Protease (1) Small Interfering RNA (siRNA) (32)
By Research Areas:	Cancer (10) Endocrinology (1) Inflammation/Immunology (1)

Inhibitors & Agonists

Screening Libraries

Recombinant Proteins

Antibodies

PIK3CA Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3CA Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3CA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3ca Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3ca Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pik3ca gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3ca Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3ca Rat Pre-designed siRNA Set A contains three designed siRNAs for Pik3ca gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3CB Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3CB Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3CB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3cb Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3cb Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pik3cb gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3CB Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3CB Rat Pre-designed siRNA Set A contains three designed siRNAs for PIK3CB gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3CD Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3CD Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3CD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3cd Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3cd Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pik3cd gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3cd Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3cd Rat Pre-designed siRNA Set A contains three designed siRNAs for Pik3cd gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3CG Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3CG Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3CG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3cg Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3cg Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pik3cg gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3cg Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3cg Rat Pre-designed siRNA Set A contains three designed siRNAs for Pik3cg gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3AP1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3AP1 Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3AP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3C3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3C3 Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3C3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3c3 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3c3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pik3c3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3c3 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3c3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Pik3c3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3IP1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3IP1 Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3IP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3R1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3R1 Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3R1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3R2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3R2 Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3R2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3R3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3R3 Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3R3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3R4 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3R4 Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3R4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3R5 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3R5 Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3R5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3R6 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3R6 Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3R6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3C2A Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3C2A Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3C2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3c2a Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3c2a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pik3c2a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3c2a Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3c2a Rat Pre-designed siRNA Set A contains three designed siRNAs for Pik3c2a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3C2B Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3C2B Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3C2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3c2b Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3c2b Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pik3c2b gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3c2b Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3c2b Rat Pre-designed siRNA Set A contains three designed siRNAs for Pik3c2b gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIK3C2G Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
PIK3C2G Human Pre-designed siRNA Set A contains three designed siRNAs for PIK3C2G gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3c2g Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3c2g Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pik3c2g gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pik3c2g Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)
Pik3c2g Rat Pre-designed siRNA Set A contains three designed siRNAs for Pik3c2g gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Demethylasterriquinone B1 DAQ B1; L-783281; Dimethylasterriquinone	Insulin Receptor Akt	Endocrinology
Demethylasterriquinone B1 is a selective insulin receptor activator. Demethylasterriquinone B1 stimulates tyrosine phosphorylation of the IR β subunit, and the activation of *PIK3* and AKT .

OMS14	PI3K	Cancer
OMS14 is exhibits inhibitory activity for phosphoinositide 3-kinase γ (PI3Kγ) and *PIK3CD/PIK3R1, which inhibits 19% PI3Kγ and 65% PIK3CD/PIK3*R1 activity at 100 μM. OMS14 exhibits anticancer efficacy in various cancer cells .

SAR405 R enantiomer	Others	Cancer
SAR405 R enantiomer is the less active enantiomer of SAR405. SAR405 is a PIK3C3/Vps34 inhibitor.

MTI-31 LXI-15029	mTOR	Inflammation/Immunology Cancer
MTI-31 (LXI-15029) is a potent, orally active and highly selective inhibitor of mTORC1 and mTORC2. MTI-31 is selective for mTOR (K_d: 0.20 nM) versus PIK3CA, PIK3CB and PIK3G with >5,000 fold selectivity in mTOR binding assays. MTI-31 shows an IC₅₀ of 39 nM for mTOR in LANCE assay of mTOR substrate phosphorylation with 100 μM ATP. MTI-31 can be used for the research of breast cancer .

MK-2206	Organoid Akt Autophagy Apoptosis	Cancer
MK-2206 is an orally active, highly potent and selective allosteric Akt inhibitor, with IC₅₀s of 8, 12, and 65 nM for Akt1, Akt2, and Akt3, respectively. Many breast cancer cell lines, and PIK3CA-mutant and cell lines with PTEN loss are sensitive to MK-2206. MK-2206 has anticancer activities .

MK-2206 free base	Organoid Akt Autophagy Apoptosis	Cancer
MK-2206 free base is an orally active, highly potent and selective allosteric Akt inhibitor, with IC₅₀s of 8, 12, and 65 nM for Akt1, Akt2, and Akt3, respectively. Many breast cancer cell lines, and PIK3CA-mutant and cell lines with PTEN loss are sensitive to MK-2206 free base. MK-2206 free base has anticancer activities .

Alpelisib 75+ Cited Publications BYL-719	PI3K	Cancer
Alpelisib (BYL-719) is a potent, selective, and orally active PI3Kα inhibitor. Alpelisib (BYL-719) shows efficacy in targeting PIK3CA-mutated cancer. Alpelisib (BYL-719) also inhibits p110α/p110γ/p110δ/p110β with IC₅₀s of 5/250/290/1200 nM, respectively. Antineoplastic activity ^[3].

BAY1082439
BAY1082439 is an orally bioavailable, selective PI3Kα/β/δ inhibitor. BAY1082439 also inhibits mutated forms of PIK3CA. BAY1082439 is highly effective in inhibiting Pten-null prostate cancer growth .

SAR405 15+ Cited Publications	PI3K Autophagy	Cancer
SAR405 is a first-in-class, selective, and ATP-competitive PI3K class III (PIK3C3) isoform Vps34 inhibitor (IC₅₀=1.2 nM; K_d=1.5 nM). SAR405 inhibits autophagy induced either by starvation or by mTOR inhibition. Anticancer activity .

Taselisib 15+ Cited Publications GDC-0032; RG-7604	PI3K	Cancer
Taselisib (GDC-0032) is a potent *PI3K* inhibitor targets PIK3CA mutations, with K_is of 0.12 nM, 0.29 nM, 0.97 nM, and 9.1 nM for PI3Kδ, PI3Kα, PI3Kγ and PI3Kβ, respectively.

Vevorisertib ARQ 751	Akt Ser/Thr Protease	Cancer
Vevorisertib (ARQ 751) is an orally active, potent and selective pan-AKT serine/threonine kinase inhibitor against AKT1 (IC₅₀=0.55 nM), AKT2 (IC₅₀=0.81 nM), and *AKT3* (IC₅₀=1.31 nM). Vevorisertib, as a single agent or in combination with other anti-cancer agents, can be used for the research of solid tumors with PIK3CA / AKT / PTEN mutations ^[3] .

CHMFL-PI3KD-317	PI3K	Cancer
CHMFL-PI3KD-317 is a highly potent, selective and orally active PI3Kδ inhibitor, with an IC₅₀ of 6 nM, and exhibits over 10-1500 fold selectivity over other class I, II and III PIKK family isoforms, such as PI3Kα (IC₅₀, 62.6 nM), PI3Kβ (IC₅₀, 284 nM), PI3Kγ (IC₅₀, 202.7 nM), PIK3C2A (IC₅₀, >10000 nM), PIK3C2B (IC₅₀, 882.3 nM), VPS34 (IC₅₀, 1801.7 nM), PI4KIIIA (IC₅₀, 574.1 nM) and PI4KIIIB (IC₅₀, 300.2 nM). CHMFL-PI3KD-317 inhibits PI3Kδ-mediated Akt T308 phosphorylation in Raji cells, with an EC₅₀ of 4.3 nM. CHMFL-PI3KD-317 has antiproliferative effects on cancer cells .

Cat. No.	Product Name

HY-L015

PI3K/Akt/mTOR Compound Library	558 compounds
The PI3K/Akt/mTOR pathway controls many cellular processes that are important for the formation and progression of cancer, including apoptosis, transcription, translation, metabolism, angiogenesis, and cell cycle progression. Every major node of this signaling network is activated in a wide range of human tumors. Mechanisms for the pathway activation include activation of receptor tyrosine kinases (RTKs) upstream of PI3K, mutation or amplification of PIK3CA encoding p110α catalytic subunit of PI3K, mutation or loss of PTEN tumor suppressor gene, and mutation or amplification of Akt1. Once the pathway is activated, signaling through Akt can stimulate a series of substrates including mTOR which is involved in protein synthesis. Thus, inhibition of this pathway is an attractive concept for cancer prevention and/or therapy. Currently some mTOR inhibitors are approved for several indications, and there are several novel PI3K/Akt/mTOR inhibitors in clinical trials. MCE owns a unique collection of 558 compounds that can be used for PI3K/Akt/mTOR pathway research. PI3K/Akt/mTOR Compound Library also acts as a useful tool for anti-cancer drug discovery.

PI3K/Akt/mTOR Compound Library

558 compounds

The PI3K/Akt/mTOR pathway controls many cellular processes that are important for the formation and progression of cancer, including apoptosis, transcription, translation, metabolism, angiogenesis, and cell cycle progression. Every major node of this signaling network is activated in a wide range of human tumors. Mechanisms for the pathway activation include activation of receptor tyrosine kinases (RTKs) upstream of PI3K, mutation or amplification of PIK3CA encoding p110α catalytic subunit of PI3K, mutation or loss of PTEN tumor suppressor gene, and mutation or amplification of Akt1. Once the pathway is activated, signaling through Akt can stimulate a series of substrates including mTOR which is involved in protein synthesis. Thus, inhibition of this pathway is an attractive concept for cancer prevention and/or therapy. Currently some mTOR inhibitors are approved for several indications, and there are several novel PI3K/Akt/mTOR inhibitors in clinical trials.

MCE owns a unique collection of 558 compounds that can be used for PI3K/Akt/mTOR pathway research. PI3K/Akt/mTOR Compound Library also acts as a useful tool for anti-cancer drug discovery.

Species:	Human (4) Mouse (1)
Tag:	His (4) GST (2) Fc (1)
Source:	HEK293 (3) Sf9 insect cells (2)

Cat. No.	Compare	Product Name	Species	Source

HY-P71204

	PIK3IP1 Protein, Human (HEK293, His) Kringle domain-containing protein HGFL; PIK3IP1; HGFL	Human	HEK293
	PIK3IP1 protein acts as a potent negative regulator of phosphatidylinositol 3-kinase (PI3K) activity in the liver. It crucially modulates the PI3K signaling pathway, exerting inhibitory control over cellular processes influenced by PI3K. PIK3IP1's regulatory function emphasizes its significance in finely tuning intracellular signaling, particularly in hepatic processes where PI3K plays a central role in various cellular functions. PIK3IP1 Protein, Human (HEK293, His) is the recombinant human-derived PIK3IP1 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of PIK3IP1 Protein, Human (HEK293, His) is 147 a.a., with molecular weight of 25-37 kDa.

HY-P77139

	PIK3IP1 Protein, Mouse (HEK293, His) Kringle domain-containing protein HGFL; PIK3IP1; HGFL	Mouse	HEK293
	The PIK3IP1 protein binds to the catalytic subunit of phosphatidylinositol 3-kinase. It negatively regulates phosphatidylinositol 3-kinase activity and signaling. PIK3IP1 Protein, Mouse (HEK293, His) is the recombinant mouse-derived PIK3IP1 protein, expressed by HEK293 , with C-His labeled tag. The total length of PIK3IP1 Protein, Mouse (HEK293, His) is 149 a.a., with molecular weight of ~23 KDa.

HY-P75310

	DAP10 Protein, Human (HEK293, mFc) Hematopoietic cell signal transducer; HCST; DAP10; KAP10; PIK3AP	Human	HEK293
	DAP10 is a transmembrane adapter protein that forms the activating receptor KLRK1-HCST, which is critical for cytotoxicity in target cells expressing stress-inducing ligands. It is activated by ULBP, triggering calcium mobilization and activating PI3K, MAP2K/ERK and JAK2/STAT5 signaling pathways. DAP10 Protein, Human (HEK293, mFc) is the recombinant human-derived DAP10 protein, expressed by HEK293 , with C-mFc labeled tag. The total length of DAP10 Protein, Human (HEK293, mFc) is 30 a.a., with molecular weight of ~33-45 kDa.

HY-P701744

	PIK3R3 Protein, Human (Sf9, His, GST) PIK3R3; Phosphatidylinositol 3-kinase regulatory subunit gamma; PI3-kinase regulatory subunit gamma; PI3K regulatory subunit gamma; PtdIns-3-kinase regulatory subunit gamma; Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma; PI3-kinase subunit p55-gamma; PtdIns-3-kinase regulatory subunit p55-gamma; p55PIK	Human	Sf9 insect cells
	PIK3R3 protein, through its SH2 domain, interacts with phosphorylated protein-tyrosine kinases, crucially regulating their kinase activity. During insulin stimulation, PIK3R3 binds to IRS-1. Operating as a heterodimer with a p110 catalytic subunit, it interacts with AXL, expanding its functional network. PIK3R3 Protein, Human (Sf9, His, GST) is the recombinant human-derived PIK3R3 protein, expressed by Sf9 insect cells , with N-8*His, N-GST labeled tag. The total length of PIK3R3 Protein, Human (Sf9, His, GST) is 460 a.a., .

HY-P701752

	PK3C3 Protein, Human (Sf9, His, GST) PIK3C3; Phosphatidylinositol 3-kinase catalytic subunit type 3; PI3-kinase type 3; PI3K type 3; PtdIns-3-kinase type 3; Phosphatidylinositol 3-kinase p100 subunit; Phosphoinositide-3-kinase class 3; hVps34	Human	Sf9 insect cells
	The PI3KC3 protein is the catalytic subunit of the PI3K complex and mediates the formation of phosphatidylinositol 3-phosphate. PI3KC3-C1 initiates autophagosomes, whereas PI3KC3-C2 promotes autophagosome maturation and endocytosis. PK3C3 Protein, Human (Sf9, His, GST) is the recombinant human-derived PK3C3 protein, expressed by Sf9 insect cells , with N-8*His, N-GST labeled tag. The total length of PK3C3 Protein, Human (Sf9, His, GST) is 886 a.a., .

Cat. No.	Product Name	Application	Reactivity

HY-P80865

PI3 Kinase p110 gamma Antibody (YA690) 1 Publications Verification PI3K; PIK3; PI3CG; PI3Kgamma; p110gamma; p120-PI3K	WB	Human
PI3 Kinase p110 gamma Antibody (YA690) is a non-conjugated and Mouse origined monoclonal antibody about 126 kDa, targeting to PI3 Kinase p110 gamma (2D10). It can be used for WB assays with tag free, in the background of Human.

HY-P82502

CLSTN1 Antibody (YA2247)

Alcadein alpha 1; alcalpha1; alcalpha2; Calsyntenin 1; CDHR12; Clstn1; CS1; CSTN1; PIK3CD; XB31alpha
WB, IHC-P, ICC/IF Human, Mouse
HY-P83078

PI 3 Kinase p150 Antibody (YA2823)

P150; Phosphoinositide 3 kinase regulatory subunit 4; PI3 kinase p150 subunit; PIK3R4; VPS15
WB, IHC-P, ICC/IF, FC Human, Mouse, Rat

HY-P81199

phospho-PI3KCA (Tyr317) Antibody PIK3CA(phospho Y317); PI3 kinase p110 subunit alpha; caPI3K; MGC142161; MGC142163; p110 alpha; Phosphatidylinositol 3 kinase catalytic alpha polypeptide; Phosphatidylinositol 3 kinase catalytic 110 KD alpha; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit alpha isoform; Phosphoinositide 3 kinase catalytic alpha polypeptide; PI3 kinase p110 subunit alpha; PI3K; PI3KC A; PIK3C A; PIK3CA; PK3CA; PtdIns 3 kinase p110; PI3-kinase P110α; PI3-kinase p110 subunit alpha; PI 3 Kinase catalytic subunit alpha; PK3CA_HUMAN; PI3 kinase P110α.	WB; ELISA; IHC-P; IHC-F; IF	Human, Mouse(predicted: Rat)
phospho-PI3KCA (Tyr317) Antibody is an unconjugated, approximately 117 kDa, rabbit-derived, anti-phospho-PI3KCA (Tyr317) polyclonal antibody. phospho-PI3KCA (Tyr317) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat background without labeling.

HY-P80867

PI3 Kinase p85 alpha Antibody (YA689) PIK3R1; GRB1; Phosphatidylinositol 3-kinase regulatory subunit alpha; PI3-kinase regulatory subunit alpha; PI3K regulatory subunit alpha; PtdIns-3-kinase regulatory subunit alpha; Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha; PI3-kinase s	WB, IHC-P	Human, Mouse, Rat
PI3 Kinase p85 alpha Antibody (YA689) is a non-conjugated and Mouse origined monoclonal antibody about 84 kDa, targeting to PI3 Kinase p85 alpha (1C8). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

HY-P80846

Phospho-PI3 Kinase p85/p55 (Tyr467/Tyr199) Antibody 1 Publications Verification PIK3R1; GRB1; Phosphatidylinositol 3-kinase regulatory subunit alpha; PI3-kinase regulatory subunit alpha; PI3K regulatory subunit alpha; PtdIns-3-kinase regulatory subunit alpha; Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha; PI3-kinase s	WB, IHC-F, IHC-P, ICC/IF, ELISA	Human, Mouse, Rat, Monkey
Phospho-PI3 Kinase p85/p55 (Tyr467/Tyr199) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 84 kDa, targeting to Phospho-PI3 Kinase p85/p55 (Tyr467/Tyr199). It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat, Monkey.

HY-P81162

PIK3CA Antibody PI3 kinase p110 subunit alpha; caPI3K; MGC142161; MGC142163; p110 alpha; Phosphatidylinositol 3 kinase catalytic alpha polypeptide; Phosphatidylinositol 3 kinase catalytic 110 KD alpha; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit alpha isoform; Phosphoinositide 3 kinase catalytic alpha polypeptide; PI3 kinase p110 subunit alpha; PI3K; PI3KC A; PIK3C A; PK3CA; PtdIns 3 kinase p110; PI3-kinase P110α; PI3-kinase p110 subunit alpha; PI 3 Kinase catalytic subunit alpha; PK3CA_HUMAN; PI3 kinase P110α.	WB; ELISA; IHC-P; IHC-F; ICC; IF	Human, Mouse, Rat(predicted: Chicken, Cow, Rabbit)
PIK3CA Antibody is an unconjugated, approximately 117 kDa, rabbit-derived, anti-PIK3CA polyclonal antibody. PIK3CA Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, rat, and predicted: chicken, cow, rabbit background without labeling.

HY-P83044

PIK3C3 Antibody (YA2789) Phosphatidylinositol 3-kinase catalytic subunit type 3 (EC:2.7.1.137); PI3-kinase type 3; PI3K type 3; PtdIns-3-kinase type 3; Phosphatidylinositol 3-kinase p100 subunit; Phosphoinositide-3-kinase class 3; hVps34; VPS34 antibodyPIK3C3；	WB, IHC-P	Human, Mouse, Rat

HY-P81872

PI3 Kinase p110 delta Antibody (YA1617) PIK3CD; Phosphatidylinositol 4; 5-bisphosphate 3-kinase catalytic subunit delta isoform; PI3-kinase subunit delta; PI3K-delta; PI3Kdelta; PtdIns-3-kinase subunit delta; Phosphatidylinositol 4; 5-bisphosphate 3-kinase 110 kDa catalytic subunit delta; PtdIns-3-kinase subunit p110-delta; p110delta	WB, ICC/IF	Human, Mouse, Rat

HY-P81229

PI3 Kinase p110 beta Antibody PI3-kinase p110 subunit beta; p110 BETA; p110Beta; PI3K beta; Phosphatidylinositol 3 kinase catalytic beta polypeptide; Phosphatidylinositol 4 5 bisphosphate 3 kinase 110 kDa catalytic subunit beta; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit beta isoform; Phosphatidylinositol-4; Phosphoinositide 3 kinase catalytic beta polypeptide; PI3 kinase p110 subunit beta; PI3-kinase subunit beta; PI3K; PI3K beta; PI3K-beta; PI3Kbeta; PI3KCB; PIK3C1; PIK3cb; PK3CB_HUMAN; PtdIns 3 kinase p110; PtdIns-3-kinase subunit beta; PtdIns-3-kinase subunit p110-beta; 5-bisphosphate 3-kinase 110 kDa catalytic subunit beta; 5-bisphosphate 3-kinase catalytic subunit beta isoform.	WB; ELISA; IHC-P; IHC-F; Flow-Cyt; ICC; IF	Human, Mouse, Rat(predicted: Dog, Cow, Horse, Rabbit)
PI3 Kinase p110 beta Antibody is an unconjugated, approximately 123 kDa, rabbit-derived, anti-PI3 Kinase p110 beta polyclonal antibody. PI3 Kinase p110 beta Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog, cow, horse, rabbit background without labeling.

HY-P81211

phospho-PI3 Kinase p110 beta (Ser1070) Antibody PI3-kinase p110 subunit beta; p-PI3Kβ(Ser1070); PI 3-kinase C2β; p110 BETA; p110Beta; Phosphatidylinositol 3 kinase catalytic beta polypeptide; Phosphatidylinositol 4 5 bisphosphate 3 kinase 110 kDa catalytic subunit beta; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit beta isoform; Phosphatidylinositol-4; Phosphoinositide 3 kinase catalytic beta polypeptide; PI3 kinase p110 subunit beta; PI3-kinase subunit beta; PI3K; PI3K beta; PI3K-beta; PI3Kbeta; PI3KCB; PIK3C1; PIK3cb; PK3CB_HUMAN; PtdIns 3 kinase p110; PtdIns-3-kinase subunit beta; PtdIns-3-kinase subunit p110-beta; 5-bisphosphate 3-kinase 110 kDa catalytic subunit beta; 5-bisphosphate 3-kinase catalytic subunit beta isoform.	WB; ELISA; IHC-P; IHC-F; IF	Human, Mouse, Rat(predicted: Chicken, Dog, Pig, Cow, Horse, Guinea Pig)
phospho-PI3 Kinase p110 beta (Ser1070) Antibody is an unconjugated, approximately 110-123 kDa, rabbit-derived, anti-phospho-PI3 Kinase p110 beta (Ser1070) polyclonal antibody. phospho-PI3 Kinase p110 beta (Ser1070) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, horse, guinea pig background without labeling.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote